Vinge has advised Bilia in connection with its bond issuance and tender offer

June 19, 2023 Banking and Finance

Vinge has advised Bilia AB in connection with its issuance of senior unsecured floating rate bonds in an amount of SEK 800 million (within a framework amount of SEK 1,500 million) and its parallel tender offer in respect of its previously issued bonds due 2023.

DNB Markets, a part of DNB Bank ASA, Sweden Branch and Nordea Bank Abp acted as joint bookrunners and dealer managers in the transaction.

The proceeds from the new bonds are applied towards the financing of the tender offer and for general corporate purposes, and the bonds are intended to listed on the corporate bond list of Nasdaq Stockholm. The bonds have a tenor of five years and were issued with a coupon of STIBOR 3m + 275 basis points.

Vinge’s team consisted of Anders Strid, Lionardo Ojeda and August Ahlin.


Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023